Kinetics of hepatitis B virus replication in anti-HBc positive/HBsAg-negative people with HIV switching to tenofovir sparing therapy
This study underlines the importance to regularly monitor anti-HBc-positive/HBsAg-negative PWH undergoing TDF/TAF-sparing regimen and the role of highly-sensitive HBV markers in optimizing their management.
Authors
- Mohammad Alkhatib (ORCID: https://orcid.org/0000-0003-0085-8990)
- Massimo Puoti (ORCID: https://orcid.org/0000-0003-3278-7138)
- Loredana Sarmati (ORCID: https://orcid.org/0000-0003-1452-0333)
- Alessandro Tavelli (ORCID: https://orcid.org/0000-0001-5899-451X)
- Eugenia Quirós-Roldán (ORCID: https://orcid.org/0000-0003-1452-9100)
- Chiara Papalini (ORCID: https://orcid.org/0000-0002-5427-8011)
- Antonella Cingolani (ORCID: https://orcid.org/0000-0002-3793-2755)
- Romina Salpini (ORCID: https://orcid.org/0000-0002-2488-2082)
- Stefano D’Anna (ORCID: https://orcid.org/0009-0003-9334-8582)
- Lorenzo Piermatteo (ORCID: https://orcid.org/0000-0002-3500-0858)
- Francesca Ceccherini‐Silberstein (ORCID: https://orcid.org/0000-0002-6024-5101)
- Livia Benedetti
- Antonella d’Arminio Monforte (ORCID: https://orcid.org/0000-0003-0073-1789)
- Valentina Svicher (ORCID: https://orcid.org/0000-0002-2377-504X)
- Carlo Federico Perno (ORCID: https://orcid.org/0000-0002-0825-5388)
- Vincenzo Malagnino (ORCID: https://orcid.org/0000-0002-6561-5298)
- Stefania Carrara
Institutions
- Università Cattolica del Sacro Cuore (IT)
- University of Rome Tor Vergata (IT)
- University of Milan (IT)
- University of Perugia (IT)
- Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani (IT)
- Ospedale San Paolo (IT)
- Bambino Gesù Children's Hospital (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- University of Milano-Bicocca (IT)
- University of Brescia (IT)
Publication Details
- Journal
- International Journal of Infectious Diseases
- Published
- 2024-11-05
- DOI
- https://doi.org/10.1016/j.ijid.2024.107294
- Citations
- 8
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 3.09
Funders
- Gilead Sciences
- ViiV Healthcare
- Ministero dell’Istruzione, dell’Università e della Ricerca
- Janssen Pharmaceuticals
- Cilag